studi
conduct
evalu
effect
person
protect
equip
ppe
sever
acut
respiratori
syndrom
sar
sixteen
patient
sar
cluster
includ
health
care
worker
hcw
nonhcw
studi
compar
initi
viral
load
nasopharyng
swab
clinic
progress
outcom
cluster
hcw
lower
viral
load
nonhcw
higher
mean
creactiv
protein
lower
oxygen
satur
higher
incid
intub
death
secondari
household
transmiss
develop
three
nonhcw
famili
one
month
discharg
nonhcw
sign
fibrosi
high
resolut
comput
tomographi
hrct
scan
impair
pulmonari
function
test
although
ppe
confer
absolut
protect
sar
seem
may
lower
exposur
viru
lead
lower
risk
secondari
transmiss
associ
rel
mild
diseas
better
earli
outcom
march
world
health
organ
issu
worldwid
alert
case
atyp
pneumonia
sever
respiratori
ill
rapidli
spread
among
hospit
staff
transmiss
rout
emerg
diseas
believ
inhal
contamin
aerosol
oral
rout
contact
contamin
environ
specif
droplet
rigor
univers
precaut
thu
recommend
healthcar
worker
hcw
take
care
patient
sever
acut
respiratori
syndrom
sar
earli
sar
epidem
investig
report
surgic
mask
equival
mask
protect
sar
later
shown
even
mask
complet
protect
confus
plu
fact
mani
hcw
becam
infect
despit
wear
mask
contribut
tremend
fear
chao
area
affect
sar
novemb
juli
total
patient
probabl
infect
sar
hcw
nosocomi
spread
one
major
strike
featur
sar
outbreak
infect
hcw
young
previous
healthi
immunocompet
mani
rel
mild
sar
infect
seem
lower
risk
death
addit
hongkong
singapor
secondari
household
transmiss
less
like
occur
hcw
famili
compar
nonhcw
outcom
sar
advers
associ
factor
old
age
increas
level
creactiv
protein
crp
even
hepat
b
carrier
also
report
higher
viral
load
nasopharyng
aspir
np
use
prognost
indic
respiratori
failur
mortal
given
np
procedur
well
standard
quit
possibl
inconsist
perform
sampl
may
render
inaccur
comparison
differ
individu
result
realtim
polymeras
chain
reaction
pcr
comparison
seri
individu
data
design
studi
explor
relationship
person
protect
equip
ppe
use
hcw
clinic
cours
outcom
viral
load
hcw
nonhcw
involv
sar
cluster
stem
exposur
singl
index
case
emerg
depart
cluster
care
select
spread
transmiss
occur
short
time
make
causerelationship
unambigu
also
use
human
intern
control
avoid
sampl
variat
although
could
control
number
factor
might
affect
transmiss
believ
worth
attempt
assess
effect
ppe
includ
mask
viral
load
subsequ
outcom
sar
mackay
memori
hospit
taiwan
teach
hospit
employ
approxim
doctor
nurs
alli
health
profession
cleric
staff
member
april
june
total
patient
diagnos
probabl
n
suspect
n
sar
treat
hospit
ward
emerg
depart
ed
sinc
may
total
neg
pressur
isol
room
includ
four
ed
establish
patient
clearli
difficult
track
clarifi
everi
transmiss
rout
face
variabl
sourc
patient
therefor
care
select
cluster
victim
whose
sourc
infect
track
back
common
index
patient
may
male
sent
ed
mackay
memori
hospit
taipei
fever
previou
day
sever
cough
dyspnea
day
cook
travel
histori
specif
contact
histori
sar
arriv
ed
given
bronchodilat
therapi
nebul
respiratori
distress
two
hour
later
chest
xray
studi
show
multifoc
air
space
consolid
patient
immedi
isol
five
hour
later
develop
intract
hypoxia
respiratori
failur
intub
mechan
ventil
twentyfour
hour
later
die
sar
ed
isol
unit
sixteen
individu
directli
secondarili
link
index
patient
includ
hcw
nonhcw
figur
subsequ
fulfil
modifi
sar
case
definit
revis
may
posit
revers
transcriptas
polymeras
chain
reaction
rtpcr
nasopharyng
swab
sarscov
posit
serolog
antibodi
test
except
die
antibodi
test
avail
clinic
cours
patient
includ
vital
sign
use
oxygen
statu
chest
xray
collect
comparison
laboratori
test
consist
consecut
hematolog
examin
includ
absolut
lymphocyt
platelet
count
serum
biochemistri
includ
lactat
dehydrogenas
ldh
creatin
kinas
ck
aspart
aminotransferas
ast
alanin
aminotransferas
alt
creactiv
protein
crp
defin
chronolog
progress
first
day
document
fever
design
fd
satur
record
admiss
hospit
nasopharyng
swab
taken
detect
sarscov
soon
patient
admit
isol
room
nasopharyng
swab
specimen
collect
trizol
reagent
total
rna
extract
accord
manufactur
instruct
gibcobrl
grand
island
ny
primer
probe
sar
cov
human
rrna
purchas
gene
express
product
appli
biosystem
foster
citi
ca
quantit
rtpcr
done
use
sarsspecif
primer
probe
prepar
gene
express
product
appli
biosystem
target
fragment
sarscov
rna
transcrib
amplifi
abi
prism
sequenc
detect
system
appli
biosystem
plasmid
suppli
center
diseas
control
taiwan
use
target
sequenc
gener
standard
curv
avoid
variat
sampl
procedur
quantit
rtpcr
also
done
sampl
intern
control
individu
quantit
rtpcr
sarscov
normal
level
studi
copiesml
initi
normal
data
compar
present
quantif
mrna
perform
use
taqman
onestep
rtpcr
master
mix
reagent
kit
appli
biosystem
realtim
fluoresc
measur
taken
cycl
threshold
ct
valu
sampl
calcul
determin
point
fluoresc
exceed
threshold
limit
standard
curv
ct
valu
obtain
serial
dilut
standard
compil
coeffici
linear
regress
slope
standard
curv
calcul
ct
valu
sampl
plot
standard
curv
calcul
number
genom
followup
protocol
surviv
patient
includ
outpati
interview
physic
examin
highresolut
comput
tomographi
hrct
scan
pulmonari
function
test
pft
walk
test
hrct
pft
perform
month
discharg
hrct
pft
done
month
discharg
hrct
imag
review
one
chest
physician
cll
one
radiologist
cy
thorax
divid
upper
middl
lower
lung
zone
hrct
find
zone
record
hrct
score
base
follow
scheme
normal
ct
mild
diseas
patch
groundglass
opacif
moder
diseas
moder
reticul
traction
bronchiectasi
peribronchovascular
thicken
sever
diseas
area
parenchym
consolid
diffus
area
peribronchovascular
thicken
traction
bronchiectasi
exampl
hrct
scan
correspond
score
shown
figur
final
hrct
score
mean
valu
score
three
zone
quantit
rtpcr
viral
rna
load
express
mean
sem
wherea
data
express
mean
sd
categor
variabl
analyz
fisher
exact
test
continu
variabl
student
test
differ
quantit
rtpcr
valu
sarscov
nasopharyng
swab
hrct
score
hcw
nonhcw
test
signific
use
mannwhitney
u
test
consid
p
signific
use
spss
softwar
spss
inc
chicago
il
analys
patient
cluster
mean
age
year
rang
hcw
younger
nonhcw
vs
year
respect
p
major
patient
femal
patient
patient
histori
smoke
chronic
obstruct
pulmonari
diseas
copd
patient
present
fever
initi
specif
manifest
sar
one
patient
copd
sever
day
high
fever
develop
respiratori
symptom
mean
incub
period
exposur
index
patient
onset
fever
day
hcw
day
nonhcw
patient
sought
medic
treatment
mean
fd
day
hcw
fd
day
nonhcw
infect
hcw
wear
ppe
includ
mask
glove
gown
head
cover
work
ed
figur
patient
care
index
patient
isol
assist
intub
wore
addit
gown
eye
protect
isol
unit
procedur
doublecheck
includ
mask
fittest
colleagu
accord
recommend
nonhcw
appar
expos
index
patient
ed
specif
protect
equip
except
wore
surgic
cloth
paper
mask
nasopharyng
swab
taken
mean
fd
day
patient
neg
isol
room
start
sar
treatment
protocol
total
sampl
obtain
patient
quantit
rtpcr
initi
rtpcr
data
show
hcw
significantli
lower
viral
load
nonhcw
vs
copiesml
respect
p
figur
hcw
also
significantli
lower
level
human
nonhcw
vs
copiesl
respect
p
indic
mucos
shed
extens
nonhcw
figur
figur
show
nonhcw
significantli
higher
viral
load
np
normal
hcw
vs
copi
rnaml
respect
although
nonhcw
still
higher
viral
load
normal
differ
tabl
nonhcw
significantli
higher
crp
valu
vs
mgdl
respect
p
lower
satur
peak
po
fio
ratio
vs
respect
p
hcw
tabl
four
nonhcw
requir
intub
die
compar
none
hcw
p
p
respect
differ
lymphocyt
platelet
count
ldh
ck
ast
alt
hcw
nonhcw
fd
abnorm
laboratori
find
occur
also
differ
significantli
two
group
secondari
household
transmiss
occur
nonhcw
famili
compar
none
hcw
famili
vs
p
three
patient
nonhcw
die
sar
surviv
patient
abl
return
normal
daili
activ
discharg
patient
normal
bodi
mass
index
tabl
howev
surviv
nonhcw
note
dyspnea
exert
followup
visit
survivor
uncompl
skin
rash
mild
hair
loss
symptom
posttraumat
stress
disord
minor
depress
also
seen
nonhcw
survivor
initi
outpati
follow
howev
symptom
gradual
improv
survivor
normal
psychosoci
daili
activ
telephon
followup
twelv
surviv
patient
complet
followup
protocol
hcrt
parenchym
abnorm
found
nonhcw
hcw
abnorm
includ
area
groundglass
opacif
reticul
vari
size
interlobular
septal
intralobular
interstiti
thicken
traction
bronchiectasi
distort
architectur
crazypav
consolid
middl
lung
zone
predominantli
involv
figur
sign
interpret
consist
pulmonari
fibrosi
parenchym
band
irregular
interfac
traction
bronchiectasi
peribronchovascular
interstiti
thicken
nonhcw
hcw
patient
patient
pneumomediastinum
hospit
spontan
resolv
followup
mass
nodul
emphysema
cavit
calcif
seen
mean
hrct
score
result
present
unnorm
row
data
normal
data
copi
rnaml
nonhcw
higher
hcw
vs
respect
p
tabl
followup
patient
signific
resolut
hrct
abnorm
previous
seen
sign
pulmonari
fibrosi
substanti
resolv
leav
mild
residu
linear
reticular
opacif
nonhcw
hcw
hrct
score
decreas
group
still
higher
nonhcw
vs
respect
p
followup
hcw
nonhcw
restrict
ventilatori
defect
vital
capac
predict
none
hcw
evid
impair
diffus
lco
predict
nonhcw
nonhcw
lower
mean
lco
hcw
vs
mlminmmhg
respect
p
tabl
function
vital
capac
total
lung
capac
mildli
decreas
hcw
respect
predict
nonhcw
respect
predict
wherea
residu
volum
markedli
reduc
predict
hcw
nonhcw
lco
correct
lung
volum
lco
v
normal
predict
hcw
nonhcw
find
suggest
parenchym
lung
damag
led
restrict
lung
defect
impair
diffus
capac
followup
lung
function
normal
hcw
nonhcw
among
latter
howev
one
person
restrict
defect
two
diffus
impair
followup
survivor
abl
perform
howev
nonhcw
walk
shorter
distanc
lower
spo
end
test
hcw
although
differ
statist
signific
tabl
describ
better
clinic
outcom
sar
hcw
compar
nonhcw
despit
involv
cluster
relat
one
index
patient
appar
directli
infect
patient
other
secondari
transmiss
sever
previou
report
sar
hcw
less
like
die
nonhcw
possibl
reason
may
often
younger
nonhcw
sought
treatment
earlier
less
like
coexist
ill
especi
diabet
mellitu
heart
diseas
also
postul
hcw
may
lower
exposur
viru
thu
lower
viral
load
possibl
due
use
ppe
initi
exposur
viru
viral
load
seem
correl
diseas
sever
specul
ppe
worn
hcw
particular
mask
may
minim
exposur
viru
result
lower
viral
load
rel
mild
diseas
cours
better
outcom
like
lower
exposur
viru
may
also
reduc
risk
secondari
household
transmiss
patient
went
japan
unknowingli
expos
index
patient
travel
compani
doctor
sever
day
develop
fever
howev
one
contact
either
among
travel
companion
japanes
becam
infect
despit
understand
fear
japan
patient
diagnos
sar
return
taiwan
none
three
hcw
transmit
diseas
cowork
famili
member
despit
contact
other
incub
period
note
isol
immedi
develop
fever
presum
also
decreas
risk
spread
patient
sar
appar
contagi
onset
fever
contrast
nonhcw
worn
mask
higher
vial
load
quantit
rtpcr
transmit
sar
famili
member
although
immedi
report
symptom
earli
diagnosi
immedi
isol
key
control
spread
sar
use
high
qualiti
mask
may
minim
initi
exposur
thu
reduc
secondari
household
transmiss
report
genet
polymorph
human
leukocyt
antigen
system
hlab
correl
risk
sever
sar
infect
hlab
seen
peopl
southern
chines
origin
northern
china
seldom
present
european
popul
cluster
nonhcw
hcw
particular
allel
howev
singl
laboratori
studi
definit
shown
defin
accur
prognosi
sar
studi
increas
ldh
elev
neutrophil
count
time
admiss
well
low
lymphocyt
count
associ
poor
prognosi
seri
crp
acutephas
protein
synthes
liver
stimulu
variou
cytokin
produc
respons
infect
inflamm
markedli
higher
nonhcw
hcw
correl
clinic
increas
risk
organ
dysfunct
poor
prognosi
heterogen
popul
critic
ill
patient
seri
greatest
hematolog
laboratori
abnorm
oxygen
desatur
occur
second
week
fever
onset
fd
fd
accord
report
hong
kong
second
week
critic
period
sar
patient
either
clinic
improv
worsen
develop
respiratori
distress
syndrom
necessit
ventilatori
support
subset
seri
author
found
second
week
mark
peak
subsequ
fall
viral
load
concurr
appear
antibodi
quantit
rtpcr
analysi
nasopharyng
swab
reveal
interest
featur
sarscov
infect
investig
report
rel
higher
concentr
viral
rna
sputum
serum
urin
stool
presenc
latter
suggest
viral
replic
occur
elsewher
addit
respiratori
tract
howev
shed
viru
respiratori
mucosa
would
seem
primari
rout
transmiss
conclus
also
support
observ
amount
viru
posit
associ
extent
mucos
shed
use
human
intern
control
sampl
found
sampl
variat
mucos
shed
may
significantli
affect
viru
number
nevertheless
find
support
content
crude
viral
load
nasopharyng
swab
correl
diseas
sever
outcom
report
patient
discharg
sar
degre
respiratori
impair
possibl
relat
residu
lung
defect
muscl
weak
system
effect
viral
ill
chest
ct
scan
reportedli
show
chang
consist
pulmonari
fibrosi
survivor
sar
week
discharg
major
patient
data
avail
ct
abnorm
interpret
fibrosi
includ
patchi
groundglass
appear
extens
might
signific
impact
lung
function
case
seri
abnorm
hrct
scan
common
nonhcw
hcw
even
month
discharg
find
predominantli
groundglass
opacif
rather
parenchym
band
therefor
suggest
potenti
revers
fibros
alveol
rather
pulmonari
fibrosi
pathophysiolog
possibl
acut
revers
lung
damag
suggest
sar
infect
might
caus
degre
chronic
viral
pneumon
addit
acut
diseas
person
commun
six
percent
sar
survivor
impair
diffus
restrict
ventilatori
defect
week
postdischarg
restrict
defect
might
attribut
skelet
muscl
weak
rather
parenchym
lung
damag
alon
muscl
weak
might
due
sever
factor
includ
use
highdos
steroid
prolong
bed
rest
lead
physic
decondit
residu
system
effect
acut
diseas
whatev
caus
outcom
small
seri
indic
lung
function
abnorm
caus
sar
may
improv
spontan
found
improv
radiolog
function
psycholog
abnorm
time
almost
half
year
sar
survivor
normal
lung
function
includ
normal
cardiopulmonari
exercis
test
data
shown
normal
psychosoci
behavior
minim
residu
radiolog
abnorm
major
limit
studi
abl
control
factor
besid
ppe
might
affect
transmiss
viru
index
case
may
includ
ventil
er
proxim
subject
index
case
durat
exposur
perhap
unknown
element
involv
transmiss
hcw
may
awar
better
hygien
practic
nonhcw
howev
exact
extent
spread
infecti
viralladen
droplet
patient
cough
difficult
determin
rtpcr
sarscov
posit
sampl
taken
floor
desk
bedrail
ed
person
commun
hcw
nonhcw
move
around
ed
certain
exactli
exposur
actual
occur
one
reason
select
one
cluster
infect
highli
like
patient
present
ed
index
patient
infect
time
anoth
limit
number
seri
small
make
statist
analysi
uncertain
howev
hcw
lower
mean
viral
load
even
though
sever
close
contact
index
patient
particularli
intub
one
would
expect
extrem
high
risk
exposur
heavi
viral
load
conclus
although
ppe
includ
mask
confer
protect
sar
infect
seem
may
lessen
initi
degre
exposur
viru
subsequ
lower
viral
load
upper
respiratori
tract
may
result
milder
diseas
clinic
less
chanc
secondari
transmiss
faster
recoveri
